Product Description:
Our 2-Hydroxyeupatolide is a high-purity extract, isolated to ensure optimal bioactivity and efficacy. Designed for researchers, nutraceutical developers, and healthcare professionals, this compound offers a promising natural alternative for various therapeutic applications.
Key Features:
– Purity: High-grade extraction to deliver over 98% purity.
– Source: Ethically sourced from plants rich in 2-Hydroxyeupatolide.
– Form: Supplied as a fine powder, ideal for formulation into supplements or for research use.
– Packaging: Available in multiple sizes, with secure packaging to protect from light and oxidation.
– Applications: Suitable for use in dietary supplements, academic research, and product development.
Potential Health Benefits:
- Anti-inflammatory Properties: These may help reduce inflammation, offering potential benefits for conditions like arthritis.
- Antimicrobial Activity: Shows promise in combating certain bacterial and fungal infections.
- Anticancer Potential: Preliminary research suggests it may inhibit the growth of certain cancer cells.
Applications:
– Dietary Supplements: These can be incorporated into formulations aimed at supporting immune health, reducing inflammation, and overall wellness.
– Pharmacological Research: A valuable natural compound for exploring new therapeutic agents.
– Functional Foods: Potential for inclusion in health-oriented food products.
Safety Information:
– Intended for professional use. Consult with a healthcare provider before using in dietary supplements or health products.
– Adhere to recommended dosages and guidelines for use.
Storage:
Store in a cool, dry place, away from direct sunlight and moisture. Ensure the container is tightly sealed to maintain product quality.
Details
Purity | – Purity: High-grade extraction to deliver over 98% purity. |
---|---|
Source | Ethically sourced from plants rich in 2-Hydroxyeupatolide. |
Form | Supplied as a fine powder, ideal for formulation into supplements or for research use. |
Reviews
There are no reviews yet.